Accelerating Cancer Research Through Comprehensive Genomic Analysis
Many techniques are currently required to characterize the full range of genomic variation that can cause or contribute to the initiation and progression of cancer.
While next-generation sequencing is becoming increasingly routine in cancer research laboratories, it fails to address a number of key genomic drivers or markers of cancer, such as structural variations, DNA methylation and transcript isoforms.
Download this whitepaper to discover how nanopore sequencing provides:
- Unrestricted read length
- Enhanced targeted sequencing capabilities
- Rapid, real-time results
- Cost-effective, scalable and on-demand analysis
